The post Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research appeared on BitcoinEthereumNews.com. Rongchai Wang Nov 07, 2025 11:54 Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions. Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle. Advancing Oncology Care The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer. Innovative Approaches in Clinical Research The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms. Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission. Data-Driven Health Innovations By integrating Oracle’s state-of-the-art AI technology… The post Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research appeared on BitcoinEthereumNews.com. Rongchai Wang Nov 07, 2025 11:54 Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions. Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle. Advancing Oncology Care The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer. Innovative Approaches in Clinical Research The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms. Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission. Data-Driven Health Innovations By integrating Oracle’s state-of-the-art AI technology…

Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research



Rongchai Wang
Nov 07, 2025 11:54

Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions.

Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle.

Advancing Oncology Care

The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care.

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer.

Innovative Approaches in Clinical Research

The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms.

Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission.

Data-Driven Health Innovations

By integrating Oracle’s state-of-the-art AI technology with real-world data from Ci4CC’s network of cancer centers, the collaboration aims to transform data into actionable knowledge that can redefine cancer research and improve patient care. This strategic partnership is part of a non-binding agreement, indicating a flexible yet committed approach to achieving their shared objectives.

Image source: Shutterstock

Source: https://blockchain.news/news/oracle-ci4cc-collaborate-enhance-ai-cancer-research

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Shocking OpenVPP Partnership Claim Draws Urgent Scrutiny

Shocking OpenVPP Partnership Claim Draws Urgent Scrutiny

The post Shocking OpenVPP Partnership Claim Draws Urgent Scrutiny appeared on BitcoinEthereumNews.com. The cryptocurrency world is buzzing with a recent controversy surrounding a bold OpenVPP partnership claim. This week, OpenVPP (OVPP) announced what it presented as a significant collaboration with the U.S. government in the innovative field of energy tokenization. However, this claim quickly drew the sharp eye of on-chain analyst ZachXBT, who highlighted a swift and official rebuttal that has sent ripples through the digital asset community. What Sparked the OpenVPP Partnership Claim Controversy? The core of the issue revolves around OpenVPP’s assertion of a U.S. government partnership. This kind of collaboration would typically be a monumental endorsement for any private cryptocurrency project, especially given the current regulatory climate. Such a partnership could signify a new era of mainstream adoption and legitimacy for energy tokenization initiatives. OpenVPP initially claimed cooperation with the U.S. government. This alleged partnership was said to be in the domain of energy tokenization. The announcement generated considerable interest and discussion online. ZachXBT, known for his diligent on-chain investigations, was quick to flag the development. He brought attention to the fact that U.S. Securities and Exchange Commission (SEC) Commissioner Hester Peirce had directly addressed the OpenVPP partnership claim. Her response, delivered within hours, was unequivocal and starkly contradicted OpenVPP’s narrative. How Did Regulatory Authorities Respond to the OpenVPP Partnership Claim? Commissioner Hester Peirce’s statement was a crucial turning point in this unfolding story. She clearly stated that the SEC, as an agency, does not engage in partnerships with private cryptocurrency projects. This response effectively dismantled the credibility of OpenVPP’s initial announcement regarding their supposed government collaboration. Peirce’s swift clarification underscores a fundamental principle of regulatory bodies: maintaining impartiality and avoiding endorsements of private entities. Her statement serves as a vital reminder to the crypto community about the official stance of government agencies concerning private ventures. Moreover, ZachXBT’s analysis…
Share
BitcoinEthereumNews2025/09/18 02:13
SEI Technical Analysis Feb 6

SEI Technical Analysis Feb 6

The post SEI Technical Analysis Feb 6 appeared on BitcoinEthereumNews.com. SEI is consolidating at the $0.08 level under general downtrend pressure; although RSI
Share
BitcoinEthereumNews2026/02/07 02:43
South Korean Crypto Exchange Accidentally Gave Away $95 Billion in Bitcoin

South Korean Crypto Exchange Accidentally Gave Away $95 Billion in Bitcoin

The post South Korean Crypto Exchange Accidentally Gave Away $95 Billion in Bitcoin appeared on BitcoinEthereumNews.com. In brief South Korean exchange Bithumb
Share
BitcoinEthereumNews2026/02/07 02:16